Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

Journal of Clinical Oncology

Volumn 14, Issue 8, 1996, Pages 2353-2364

  Gill, P S ^a   Wernz, J ^a   Scadden, D T ^a   Cohen, P ^a   Mukwaya, G M ^a   von Roenn, J H ^a   Jacobs, M ^a   Kempin, S ^a   Silverberg, I ^a   Gonzales, G ^a   Rarick, M U ^a   Myers, A M ^a   Shepherd, F ^a   Sawka, C ^a   Pike, M C ^a   Ross, M E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DAUNORUBICIN; LIPOSOME; VINCRISTINE;

ADULT; AIDS RELATED COMPLEX; ALLERGIC REACTION; ALOPECIA; ANEMIA; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG FORMULATION; DRUG RESPONSE; DYSPNEA; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; THROMBOCYTOPENIA; TREATMENT FAILURE;

EID: 9444258072     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.8.2353     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report. Atlanta, GA, Centers for Disease Control, February 1-23, 1993
2. Meduri GU, Stover DE, Lee M, et al: Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome: Clinical, radiographic, and pathologic manifestations. Am J Med 81:11-18, 1986
3. Fischl MA, Krown SE, O'Boyle KP, et al: Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. J AIDS 6:259-264, 1993
4. Remick SC, Reddy M, Herman D, et al: Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma. J Clin Oncol 12:1130-1136, 1994
5. Mintzer D, Real FX, Jovino L, et al: Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 102:200-202, 1985
6. Volberding P, Abrams DI, Conant M, et al: Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 103:335-338, 1985
7. Laubenstein LJ, Kriegel RL, Odajnk CM, et al: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin. and vinblastine. J Clin Oncol 2:1115-11120, 1984
8. Saville MW, Lietzau J, Pluda JM, et al: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346:26-28, 1995
9. Shepherd FA, Burkes RL, Paul KE, et al: A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS. 5:305-309, 1991
10. Gill PS, Rarick MU, Espina B, et al: Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy. Cancer 65:1074-1078, 1990
11. Gill PS, Miles SA, Mitsuyasu RT, et al: Phase I AIDS Clinical Trials Group (075) study of Adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS 8:1695-1699, 1994
12. Mitsuyasu R, Gill P, Paredes J, et al: Combination chemotherapy, Adriamycin, bleomycin, vincristine (ABV) with dideoxyinosine (ddI) or dideoxycytidine (ddC) in advanced AIDS-related Kaposi's sarcoma (ACTG 163). Proc Am Soc Clin Oncol 14:289, 1995 (abstr 822)
13. Gill PS, Akil B, Colletti P, et al: Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy. Am J Med 87:57-61, 1989
14. Gill PS, Rarick M, McCutchan JA, et al: Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial. Am J Med 90:427-433, 1991
15. Forssen EA, Ross ME: DaunoXome treatment of solid tumors: Preclinical and clinical investigations. J Liposome Res 4:481-512, 1994
16. Gill PS, Espina BM, Muggia F, et al: Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 13:996-1003, 1995
17. Forssen EA, Coulter DM, Proffitt RT: Selective in vitro localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res 52:3255-3261, 1992
18. Presant CA, Scolaro M, Kennedy R, et al: Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet 341:1242-1243, 1993
19. Money-Kyrle JF, Bates F, Ready J, et al: Liposomal daunorubicin in advanced Kaposi's sarcoma: A phase II study. Clin Oncol 5:367-371, 1993
20. Bogner JR, Kronawitter V, Rolinski B, et al: Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi's sarcoma. J AIDS 7:463-468, 1994
21. Harrison M, Tomlinson D, Stewart S: Liposomal-entrapped doxorubicin: An active agent in AIDS-related Kaposi's sarcoma. J Clin Oncol 13:914-920, 1995
22. Krown SE, Metroka C, Wernz J: Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7:1201-1207, 1989
23. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34:585-612, 1976
24. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
25. Krown SE: The role of Interferon in the therapy of epidemic Kaposi's sarcoma. Semin Oncol 14:27-33, 1987
26. Hoover DR, Black C, Jacobson LP, et al: Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 138:266-278, 1993